Animal & Veterinary
CVM SCIENTISTS WIN AWARDS - July/August 2002
FDA Veterinarian Newsletter 2002 Volume XVI, No IV
At the 2002 FDA Scientific Achievement Awards Ceremony, held on February 21, 2002, the following CVM scientists were recognized:
- EXCELLENCE IN ANALYTICAL SCIENCE
Raafat Fahmy, Ph.D. - For excellence in developing novel methods for the dissolution of aspirin, sulfas and tetracycline boluses, a unique dosage form, using standard USP apparatus and environmentally sound solvents.
- EXCELLENCE IN LABORATORY SCIENCE
Patrick F. McDermott, Ph.D. - For demonstrating the impact the use of fluoroquinolones in chickens has on the selection for fluoroquinolone resistant Campylobacter.
- EXCELLENCE IN REVIEW SCIENCE
Tania Denise Woerner, V.M.D. - Dr. Woerner utilized a novel approach to corroborate the findings of a clinical study for the approval of ponazuril to treat Equine Protozoal Myeloencephalitis (EPM).
OUTSTANDING INTER-CENTER SCIENTIFIC COLLABORATION
Phenylbutazone Residue Group - ORA
Denver District Laboratory
- Karen S. Kreuzer
- Mark R. Madson
- Sherri B. Turnipseed, Ph.D.
- Susan B. Clark
- Gene J. Nandrea
- William B. Martin, Ph.D.
- W. Douglas Rowe
- Lara L. Murphy
- John N. Sofos
Seattle Regional Laboratory
- Jeffrey A. Hurlbut, Ph.D.
- Deborah A. Cera
- John O'Rangers, Ph.D.
- Michael H. Thomas
- Mary C. Carson, Ph.D.
- David N. Heller
For protection of the Public's Health through the reduction of Phenylbutazone abuse in food-producing animals through analytical surveillance, education and regulatory actions.
CVM is proud of these accomplishments and congratulates all FDA award winners.